BioSyent Inc. (TSXV:RX)
Canada
· Delayed Price · Currency is CAD 11.09
-0.01 (-0.09%)
Feb 21, 2025, 3:50 PM EST
BioSyent Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 125 | 108 | 85 | 104 | 101 | 83 | Upgrade
|
| Market Cap Growth | 34.24% | 28.05% | -18.50% | 2.59% | 22.26% | -29.22% | Upgrade
|
| Enterprise Value | 109 | 80 | 58 | 78 | 79 | 65 | Upgrade
|
| Last Close Price | 11.09 | 9.05 | 6.73 | 7.90 | 7.57 | 5.83 | Upgrade
|
| PE Ratio | 18.53 | 16.79 | 15.51 | 16.54 | 26.69 | 18.96 | Upgrade
|
| Forward PE | 14.64 | 17.23 | 13.86 | 18.77 | 21.67 | 17.18 | Upgrade
|
| PS Ratio | 3.75 | 3.43 | 3.03 | 3.63 | 4.54 | 3.87 | Upgrade
|
| PB Ratio | 3.44 | 3.12 | 2.54 | 3.29 | 3.78 | 3.21 | Upgrade
|
| P/TBV Ratio | 3.89 | 3.21 | 2.62 | 3.38 | 3.92 | 3.35 | Upgrade
|
| P/FCF Ratio | 18.78 | 21.71 | 17.28 | 22.64 | 14.72 | 21.26 | Upgrade
|
| P/OCF Ratio | 18.47 | 21.45 | 17.11 | 22.23 | 14.69 | 18.82 | Upgrade
|
| EV/Sales Ratio | 3.16 | 2.55 | 2.09 | 2.74 | 3.55 | 3.03 | Upgrade
|
| EV/EBITDA Ratio | 12.68 | 10.36 | 8.03 | 9.26 | 14.78 | 10.05 | Upgrade
|
| EV/EBIT Ratio | 13.18 | 10.76 | 8.36 | 9.58 | 15.77 | 10.37 | Upgrade
|
| EV/FCF Ratio | 16.38 | 16.10 | 11.90 | 17.08 | 11.53 | 16.65 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 0.13 | 0.15 | 0.19 | 0.18 | 0.31 | 0.29 | Upgrade
|
| Debt / FCF Ratio | 0.16 | 0.24 | 0.28 | 0.34 | 0.25 | 0.48 | Upgrade
|
| Asset Turnover | 0.79 | 0.77 | 0.72 | 0.81 | 0.69 | 0.69 | Upgrade
|
| Inventory Turnover | 1.39 | 1.15 | 1.50 | 2.80 | 2.33 | 2.64 | Upgrade
|
| Quick Ratio | 3.04 | 5.36 | 5.63 | 7.49 | 5.33 | 7.16 | Upgrade
|
| Current Ratio | 3.92 | 6.48 | 6.49 | 8.24 | 5.79 | 7.99 | Upgrade
|
| Return on Equity (ROE) | 19.77% | 18.97% | 16.82% | 21.53% | 14.43% | 16.36% | Upgrade
|
| Return on Assets (ROA) | 11.91% | 11.39% | 11.24% | 14.46% | 9.74% | 12.59% | Upgrade
|
| Return on Capital (ROIC) | 13.94% | 13.20% | 12.86% | 16.60% | 11.20% | 14.16% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.53% | 20.76% | 20.08% | 24.77% | 17.69% | 22.67% | Upgrade
|
| Earnings Yield | 5.68% | 5.96% | 6.45% | 6.05% | 3.75% | 5.27% | Upgrade
|
| FCF Yield | 5.32% | 4.61% | 5.79% | 4.42% | 6.79% | 4.70% | Upgrade
|
| Dividend Yield | 1.62% | 1.77% | 0.59% | - | - | - | Upgrade
|
| Payout Ratio | 28.69% | 29.61% | 8.87% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 3.05% | 2.95% | 2.57% | 1.70% | 6.10% | 4.06% | Upgrade
|
| Total Shareholder Return | 4.67% | 4.72% | 3.16% | 1.70% | 6.10% | 4.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.